about
Linking the Resource Description Framework to cheminformatics and proteochemometricsProteochemometric modeling of the susceptibility of mutated variants of the HIV-1 virus to reverse transcriptase inhibitorsEnzymatic analysis of recombinant Japanese encephalitis virus NS2B(H)-NS3pro protease with fluorogenic model peptide substratesA unified proteochemometric model for prediction of inhibition of cytochrome p450 isoformsProteochemometric modeling of HIV protease susceptibility.Proteochemometrics analysis of substrate interactions with dengue virus NS3 proteases.Kinome-wide interaction modelling using alignment-based and alignment-independent approaches for kinase description and linear and non-linear data analysis techniques.Origin of aromatase inhibitory activity via proteochemometric modeling.Proteochemometric model for predicting the inhibition of penicillin-binding proteins.Towards Proteome-Wide Interaction Models Using the Proteochemometrics Approach.Design and evaluation of substrate-based octapeptide and non substrate-based tetrapeptide inhibitors of dengue virus NS2B-NS3 proteases.Reductive amination products containing naphthalene and indole moieties bind to melanocortin receptors.Introduction to Pharmaceutical BioinformaticsProteochemometric modeling of drug resistance over the mutational space for multiple HIV protease variants and multiple protease inhibitors.Illuminating the origins of spectral properties of green fluorescent proteins via proteochemometric and molecular modeling.Services for prediction of drug susceptibility for HIV proteases and reverse transcriptases at the HIV drug research centre.Chemoinformatics Taking Biology into Account: ProteochemometricsExtending proteochemometric modeling for unraveling the sorption behavior of compound–soil interactionIdentification and analysis of functionally important amino acids in human purinergic 12 receptor using a Saccharomyces cerevisiae expression system
P50
Q27062639-C157C128-3F9A-4E3D-AF75-3E4EC97ADC89Q28476537-348673EC-1815-4A81-B058-80E2FDEB3584Q28483739-ED181AD3-0A78-46E2-9AD8-C296847072E3Q28533964-8A789CAD-0F0B-41C5-BFEC-537BC89622A0Q33327559-1ACE60DB-35F7-4C10-9E1C-C84C95F3D17BQ33372676-F9E07BA3-ABDA-4C33-A47C-D0C9EA66828BQ33612912-9922F2F3-75A2-4C90-92E2-6DE99AA63218Q36905373-BBA5935F-D409-4CBC-BDF3-91D17AA5D4FBQ39108153-9DB586E0-B859-4FCA-9425-E1632E3B9EECQ39554959-51C5FA0F-E6A5-40E2-99EF-80988D7151ECQ40251092-14AE4654-F085-4AF3-BD7A-448F4C33C0E8Q40743011-96FA3177-0D47-49EF-A0ED-2C7257C54DADQ47543807-12887251-4505-1106-7adc-caaf9201a8aaQ47948628-26AC45A7-67FD-4B05-9CD4-4DAAD4C92FBCQ50451269-70770E93-2F28-4628-81CB-D1A7618D36A8Q54596511-1DBFCAFF-4616-4669-A3E5-CB62E4EC91B5Q56914186-F5683DBB-5AE2-4CD2-BF93-60DE080203EEQ56920888-482D8A52-B29B-40A0-BAE8-2618BCACA303Q56920902-7C803666-BA99-4DA6-9D81-5844E017CCF4
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Maris Lapins
@ast
Maris Lapins
@en
Maris Lapins
@es
Maris Lapins
@nl
Maris Lapins
@sl
type
label
Maris Lapins
@ast
Maris Lapins
@en
Maris Lapins
@es
Maris Lapins
@nl
Maris Lapins
@sl
prefLabel
Maris Lapins
@ast
Maris Lapins
@en
Maris Lapins
@es
Maris Lapins
@nl
Maris Lapins
@sl
P106
P1153
15825336300
P21
P2456
P31
P496
0000-0002-0122-6680
P569
2000-01-01T00:00:00Z